The intrinsic brittleness of poly(lactide) (PLA) remains a major limitation for applications requiring a suitable balance between stiffness and toughness. In this work, four bio-based fumaric acid esters with different alkyl-chain lengths and architectures, namely diethyl fumarate (DEF), diisopropyl fumarate (DPF), dibutyl fumarate (DBF), and bis(2-ethylhexyl) fumarate (DEHF), were evaluated as plasticizers for PLA. Formulations containing 10 and 20 wt% of each fumarate were prepared by melt extrusion followed by injection molding and characterized in terms of their mechanical, morphological, chemical, thermal, viscoelastic, thermomechanical, and migration behavior. At 10 wt%, none of the fumarates induced a brittle-to-ductile transition, and the formulations largely retained the rigid and brittle mechanical response of neat PLA. In contrast, the incorporation of 20 wt% of DEF, DPF, and DBF produced pronounced plasticization, with substantial reductions in stiffness and glass transition temperature and an increase in elongation at break from 6.7% for neat PLA to 212.9–326.0%. Conversely, PLA formulations plasticized with DEHF exhibited a markedly different behavior. Even at 20 wt%, DEHF retained comparatively high stiffness, showed a smaller reduction in glass transition temperature, and maintained good dimensional stability, while improving Charpy impact strength from 4.8 to 8.5 kJ m −2 . Overall, the results demonstrate that the plasticization efficiency and retention of fumaric acid esters are strongly governed by their molecular architecture. Short- and medium-chain fumarates provide highly ductile PLA formulations, whereas the bulky and branched structure of DEHF promotes enhanced toughness while preserving comparatively high rigidity.
No takes yet. Share an insight, caveat, or question.
Vicente-Vinas et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: